Coldstream Capital Management’s 2seventy bio TSVT Stock Holding History
Bought
Maintained
Sold
Other funds holding TSVT
Coldstream Capital Management's TSVT Position: Q2 2025 in Review
Coldstream Capital Management sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 172 shares — an estimated $850 sold.
Coldstream Capital Management first reported a position in TSVT in Q1 2025 and held it in 1 quarter. The position peaked at $850 in Q1 2025. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.
- Coldstream Capital Management reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
- Coldstream Capital Management sold 172 2seventy bio shares in Q2 2025, an estimated $850.
- Coldstream Capital Management first reported a position in 2seventy bio in Q1 2025 and held it in 1 quarter.
- Coldstream Capital Management's 2seventy bio position peaked at $850 in Q1 2025.
- 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.
Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.